Advancing Drug Discovery
Kantify has built a platform to accelerate the discovery of new drugs in silico. This next generation technology called ZeptoNet enables our pharma and biotech partners to improve target identification, hit discovery, hit optimization and ADMET optimization thanks to Artificial Intelligence. The technology has shown extremely promising results in several diseases including rare diseases.
Diagnosis and Clinical Decision Support
Kantify is developing AI solutions for diagnosis and clinical decision support. As a CRO, we help developing solutions in oncology, ophthalmology, hematology and other. Our expertise in AI for healthcare enables us to understand and tackle challenges in various therapeutical areas, using different datasets and sources.
Kantify is enabling life science organizations to accelerate the analysis of data, samples and other kind of clinical data thanks to Artificial Intelligence. Our expertise in several techniques within Artificial Intelligence enables us to tackle various kinds of data and technical challenges.
Related Use Cases
Analyzing human fertility using Artificial Intelligence
Using Artificial Intelligence (AI) for male fertility diagnostic
Advancing Drug Discovery with Artificial Intelligence
Discover how to enhance your drug discovery pipeline using our novel Artificial Intelligence technology
Using AI for blood cell analysis and hematology
Detect, count, and classify individual blood cells with Artificial Intelligence
Predicting Atrial Fibrillation with AI
Predict and detect an episode of Atrial Fibrillation (arrhythmia) with Artificial Intelligence (AI)
Early detection of ocular pathologies with AI
Detect early signs of diabetic retinopathy in patients with Artificial Intelligence (AI)
Embedding artificial intelligence into Medical Devices
Power precision medicine and expand the capabilities of your medical devices with Artificial Intelligence (AI)
Surgery Optimization with AI
Minimize the risk of potential surgery complications and improve patients surgical outcomes with Artificial Intelligence (AI)
Fri 19 Mar 2021
ZeptoNet White Paper: AI for drug discovery
We present ZeptoNet, our novel machine learning technology for in silico small molecule screening at scale
Tue 15 Dec 2020
Artificial Intelligence in medical devices
Discover the current state of AI in medical devices, its benefits, and future trends
Wed 14 Apr 2021
The CEO of Kantify interviews with DataNews
The CEO of Kantify speaks about her journey in AI and the potential of AI in the healthcare industry
Fri 26 Mar 2021
Is your AI software a medical device as per the MDR & IVDR?
The European Commission publishes decision steps for the qualification of softwares medical devices.
Wed 24 Mar 2021
European Commission Report on AI Uptake in Healthcare
The European Commission publishes a report to monitor the development, uptake and impact of Artificial Intelligence for healthcare.
Tue 16 Mar 2021
Kantify at the Belgian AI Week 2021
Kantify is taking part in several events on Artificial Intelligence (AI) during the 2021 Belgian AI Week.